• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROMODULATION ENTERRA; INTESTINAL STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROMODULATION ENTERRA; INTESTINAL STIMULATOR Back to Search Results
Model Number 37800
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Nausea (1970); Pain (1994); Complaint, Ill-Defined (2331); Abdominal Distention (2601)
Event Type  Injury  
Manufacturer Narrative
Concomitant medical products: product id: 4351-35.Implanted: (b)(6) 2018, product type: lead; product id: 4351-35, implanted: (b)(6) 2018, product type: lead.If information is provided in the future, a supplemental report will be issued.
 
Event Description
The patient¿s healthcare provider reported via manufacture representative that the patient presented at the clinic on (b)(6) 2018 for a routine checkup.The nurse made step changes from 5 ma to 7.5 ma as per pathway as the patient still experienced nausea although there was improvement.The patient reported a distended tummy and pain after one-hour post programming change.It was noted that at the patient¿s previous appointment only a nominal change had occurred.No environmental/external/patient factors were noted that may have led or contributed to the issue.The patient was scheduled to see their healthcare provider on (b)(6) 2018 to change the settings back to 5 ma.No further complications were reported.Additional information reported that had volvulus, ischaemic bowel and had a right side hemicolectomy.It was unknown if the event was resolved.No further complications were reported.Additional information reported that the patient was discharged (b)(6) 2018 and had a follow up in the clinic (b)(6) 2019.The patient¿s healthcare provider did not feel that the volvulous was connected to the device programming.
 
Manufacturer Narrative
Continuation of concomitant medical products: product id: 4351-35, serial# unknown, implanted: (b)(6) 2018, product type: lead; product id: 4351-35, serial# unknown, implanted: (b)(6) 2018, product type: lead.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information reported that the patient is well, the issue resolved and there appeared to be no connection to enterra.No further complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENTERRA
Type of Device
INTESTINAL STIMULATOR
Manufacturer (Section D)
MEDTRONIC NEUROMODULATION
800 53rd ave ne
minneapolis MN 55421 1200
Manufacturer (Section G)
MEDTRONIC NEUROMODULATION
800 53rd ave ne
minneapolis MN 55421 1200
Manufacturer Contact
lisa woodward clark
7000 central avenue ne rcw215
minneapolis, MN 55432
7635263920
MDR Report Key8157251
MDR Text Key130172183
Report Number3007566237-2018-03581
Device Sequence Number1
Product Code LNQ
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
H990014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 01/31/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number37800
Device Catalogue Number37800
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 11/16/2018
Initial Date FDA Received12/12/2018
Supplement Dates Manufacturer Received01/23/2019
Supplement Dates FDA Received01/31/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age46 YR
-
-